UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000012035
Receipt No. R000014067
Official scientific title of the study Feasibility Study to Assess Diagnostic Accuracy of Pathological Complete Response with Core Needle Biopsy
Date of disclosure of the study information 2013/10/15
Last modified on 2018/04/23 (Ver. 7)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Feasibility Study to Assess Diagnostic Accuracy of Pathological Complete Response with Core Needle Biopsy
Title of the study (Brief title) CNB for Breast Cancer Acquired cCR with NAC
Region
Japan

Condition
Condition Invasive Breast Cancer
Classification by specialty
Breast surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To assess feasibility of diagnostic accuracy of pathological complete response (pCR) with core needle biopsy(CNB) for breast cancer patient who acquired clinical complete response (cCR) with neoadjuvant chemothrapy. If pCR is diagnosed with CNB correctly, we have opportunity to omit surgical procedure for resection.
Basic objectives2 Others
Basic objectives -Others Feasibility study to assess diagnostic accuracy of pathological complete response with core needle biopsy.
Trial characteristics_1 Exploratory
Trial characteristics_2 Explanatory
Developmental phase Not applicable

Assessment
Primary outcomes Accuracy of pCR with CNB
Key secondary outcomes Accuracy of pCR with imaging study.

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Prevention
Type of intervention
Maneuver
Interventions/Control_1 Core needle biopsy is performed just before resection of the primary lesion under general anesthegia for the resection procedure.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
75 years-old >
Gender Female
Key inclusion criteria 1) Woman age of 20 to 75 years old at registration.
2) Invasive breast cancer proven by core biopsy.
3) Negative for estrogen receptor immunohistochemically.
4) No prior therapy including radiation, endocrine therapy or immunotherapy except for neoadjuvant chemotherapy for existing breast cancer.
5) Expected complete response for invasive cancer by neoadjuvant chemotherapy with imaging study.
6) Informed consent must be obtained before patient registration.
Key exclusion criteria 1) Male gender
2) Judged to be inadequate by the doctor.
Target sample size 80

Research contact person
Name of lead principal investigator Kazutaka Narui
Organization Yokohama City University Medical Center
Division name Department of Breast and Thyroid Surgery
Address 4-57 Urafune-cho, Minami-ku, Yokohama City, 232-0024, Japan
TEL 045-261-5656
Email nr1@gc5.so-net.ne.jp

Public contact
Name of contact person Kazutaka Narui
Organization Yokohama City University Medical Center
Division name Department of Breast and Thyroid Surgery
Address 4-57 Urafune-cho, Minami-ku, Yokohama City, 232-0024, Japan
TEL 045-261-5656
Homepage URL
Email nr1@gc5.so-net.ne.jp

Sponsor
Institute Yokohama City University Medical Center
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 横浜市立大学附属市民総合医療センター(神奈川県)
東海大学付属病院(神奈川県)
聖マリアンナ医科大学病院(神奈川県)
聖マリアンナ医科大学ブレスト&イメージング(神奈川県)
北里大学病院(神奈川県)
神奈川県立がんセンター(神奈川県)
大船中央病院(神奈川県)
横浜労災病院(神奈川県)
湘南記念病院(神奈川県)
横浜市立みなと赤十字病院(神奈川県)
横浜旭中央総合病院(神奈川県)
東海大学付属八王子病院(神奈川県)
横浜市立大学附属病院(神奈川県)
弘前市立病院(青森県)
東京医科大学八王子医療センター(東京都)

Other administrative information
Date of disclosure of the study information
2013 Year 10 Month 15 Day

Progress
Recruitment status Completed
Date of protocol fixation
2013 Year 09 Month 04 Day
Anticipated trial start date
2013 Year 10 Month 15 Day
Last follow-up date
2015 Year 09 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2013 Year 10 Month 15 Day
Last modified on
2018 Year 04 Month 23 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000014067